EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People

Ashby F Walker iD, Michael J Haller iD, Ananta Addala iD, Stephanie L Filipp, Rayhan A Lal iD, Matthew J Gurka iD, Lauren E Figg, Melanie Hechavarria, Dessi P Zaharieva iD, Keilecia G Malden, Korey K Hood iD, Sarah C Westen und 6 weitere

Diabetes Care · 01.02.2025 · 48 (2) · 243-250

DOI: 10.2337/dc24-2100 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Care, online erschienen am 17.12.2024. Verfasst von Ashby F Walker und 17 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida Diabetes Institute, Gainesville, FL. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Medically Underserved Area, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE The Project Extension for Community Healthcare Outcomes (ECHO) model is used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach. Few studies have rigorously evaluated the impact of the program on patient outcomes using randomized designs. RESEARCH DESIGN AND METHODS Implementation of an ECHO Diabetes program was evaluated using a stepped-wedge design with recruitment of 20 federally qualified health centers (FQHCs) across California and Florida with randomized, phased-in intervention entry. Participating FQHCs (referred to as “spokes”) provided aggregate data, including the Healthcare Effectiveness Data and Information Set (HEDIS) and diabetes technology use. Patients were recruited from spokes, and data collection involved historical and prospective HbA1c measures, HEDIS markers, and pre/post surveys. Linear mixed models were used to generate patient-level monthly HbA1c estimates and evaluate change over time; Poisson regression was used to model clinic-level technology use. RESULTS The spoke-level cohort included 32,796 people with type 1 diabetes (T1D; 3.4%) and type 2 diabetes (T2D; 96.6%), of whom 72.7% were publicly insured or uninsured. The patient-level cohort included 582 adults with diabetes (33.0% with T1D, 67.0% with T2D). Their mean age was 51.1 years, 80.7% were publicly insured or uninsured, 43.7% were non-Hispanic White, 31.6% were Hispanic, 7.9% were non-Hispanic Black, and 16.8% were in other race/ethnicity categories. At the spoke level, there were statistically significant reductions before and after the intervention in the proportion of people with HbA1c >9% (range 31.7% to 26.7%; P = 0.033). At the patient level, there were statistically significant increases in those using continuous glucose monitoring (range 25.1% to 36.8%; P < 0.0001) and pump use (range 15.3% to 18.3%; P < 0.001) before and after the intervention. CONCLUSIONS The ECHO model demonstrates promise for reducing health disparities in diabetes and contributes to our understanding of program benefits beyond the provider level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Medically Underserved AreaDiabetes Mellitus, Type 1HumansFemaleMaleMiddle AgedAdultGlycated HemoglobinCaliforniaTelemedicineFlorida

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • University of Florida Diabetes Institute, Gainesville, FL.
  • Department of Health Services Research, Management and Policy, University of Florida, Gainesville, FL.
  • Division of Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL.
  • Stanford Diabetes Research Center, Stanford, CA.
  • Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Department of Pediatrics, University of Florida, Gainesville, FL.

ORCID-Profile: Ashby F Walker, Michael J Haller, Ananta Addala, Rayhan A Lal, Matthew J Gurka, Dessi P Zaharieva, Korey K Hood, Jessie J Wong, Angelina V Bernier

Förderung

  • Leona M. and Harry B. Helmsley Charitable Trust

Zitieren

APA

Walker, A. F., Haller, M. J., Addala, A., Filipp, S. L., Lal, R. A., Gurka, M. J., Figg, L. E., Hechavarria, M., Zaharieva, D. P., Malden, K. G., Hood, K. K., Westen, S. C., Wong, J. J., Donahoo, W. T., Basina, M., Bernier, A. V., Maahs, D. M., & ECHO Diabetes Study Team (2025). Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People. Diabetes Care, 48(2), 243-250. https://doi.org/10.2337/dc24-2100

Vancouver

Walker AF, Haller MJ, Addala A, Filipp SL, Lal RA, Gurka MJ, et al. Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People. Diabetes Care. 2025;48(2):243-250. doi:10.2337/dc24-2100

BibTeX
@article{Walker2025,
  author = {Walker, Ashby F and Haller, Michael J and Addala, Ananta and Filipp, Stephanie L and Lal, Rayhan A and Gurka, Matthew J and Figg, Lauren E and Hechavarria, Melanie and Zaharieva, Dessi P and Malden, Keilecia G and Hood, Korey K and Westen, Sarah C and Wong, Jessie J and Donahoo, William T and Basina, Marina and Bernier, Angelina V and Maahs, David M and ECHO Diabetes Study Team, ECHO Diabetes Study Team},
  title = {Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People},
  journal = {Diabetes Care},
  year = {2025},
  volume = {48},
  number = {2},
  pages = {243--250},
  doi = {10.2337/dc24-2100}
}
Kostenlos starten →